Navigation Links
Ethanol Confirmation/Quantitation, Urine

ProductsEthanol Confirmation/Quantitation, Urine
Company ARUP Laboratories
Item Ethanol Confirmation/Quantitation, Urine
Features 
Description ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics.
Info ARUP Laboratories
Customer Service: (800) 522-2787
Web site: http://www.aruplab.com

Related medicine products :

1. Liquichek Ethanol/Ammonia Control
2. Blood Ethanol Level
3. Ethanol, Urine, Qualitative-Medical
4. Ethanol, Serum or Plasma-Medical
5. Ethanol, Urine-Medical
6. 6-Acetylmorphine Confirmation/Quantitation, Urine
7. Alcohol Confirmation/Quantitation, Urine
8. Amphetamines Confirmation/Quantitation, Meconium
9. Amphetamines Confirmation/Quantitation, Urine
10. Barbiturates Confirmation/Quantitation, Urine
11. Barbiturates Confirmation/Quantitation, Meconium
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
Medicine Products:
(Date:12/3/2008)...he American College of Surgeons (ACS) today recogn...ttee report on resident duty hours that was releas...timizing Graduate Medical Trainee (Resident) Hours..., , ACS agrees with the IOM in its conclusio...work week (averaged over four weeks) are not advis...
(Date:12/3/2008)...fic Gamma Imaging (BSGI) has,equivalent sensitivi...nts with,inconclusive findings after mammography ... according to findings presented today at the annu...merica (RSNA). BSGI is a molecular breast,imaging...hy that can identify,lesions independent of tissu...
(Date:12/3/2008)...idelines, , , WEDNESDAY, Dec. 3 (Heal...sure drugs was more effective than a diuretic-base...ascular problems and death in people with high blo...re than 11,000 patients in the United States, Swed... took either a tablet containing benazepril (an AC...
(Date:12/3/2008)...re/ -- The following is a statement by Betsy Ryan,...n: , , "State officials today announced tha... the state,s $44 million Healthcare Stabilization ...t the more sobering headline is the fact that seve... While a worthy effort, clearly the needs of New J...
Breaking Medicine News(10 mins):Health News:American College of Surgeons Comments on Institute of Medicine Report on Resident Duty Hours 2Health News:Molecular Breast Imaging Outperforms MRI for Patients With Inconclusive Results in the Diagnosis of Cancer 2Health News:Blood Pressure Pill Combo More Effective Than Diuretics 2
...ination of early pregnancies, might be helpful to ...ts reported this from the University of California...'Science'.Mifepristone or RU486 is a licensed drug...ancy, progesterone is the hormone that helps to ma...
...roduced in Hong Kong following a series of scares ...nced Thursday.// The measures will allow the gover...aw food from sale if there are concerns, the terri...York Chow announced. The move comes after scares ...
...o Sorbent Test’ (RAST) machine, has been designed ... track down the source allergen. An allergy is re...e, which it perceives as unsuitable. Hay fever, mi...estive disturbances, eczema and sinusitis are some...
...e country Myanmar did not give him more than six m...hope //and new life in a Delhi hospital which succ...The businessman from Mandalay underwent a 10-hour ...nga Ram Hospital, a leading private hospital in th...
Other Medicine News:Health News:Breast Cancer Prevention Using Abortion Drug Considered 2Health News:Hong Kong to Tighten Food Safety Laws 2Health News:Myanmar National Undergoes Successful Liver Transplantation in Delhi 2
(Date:12/3/2008)...viates long-term anemia and organ damage in mice a... MEMPHIS, Tenn., Dec. 3 /PRNewswire-USNewswire/ -...ne into mouse blood cells, scientists at St. Jude ...e cell disease pathology. In their studies, the re...tially no difference from normal mice. Although th...
(Date:12/3/2008)... Bionovo, Inc.,(Nasdaq: ... the company,s,manufacturing and control process ...how Bionovo can move forward with the development ...hot flashes. , "We have concluded three CMC...ess the Agency,s recommendations for further devel...
(Date:12/2/2008)...swire/ -- IBT Laboratories, a leading clinical-di...alizing in immunology and allergy assays, announce... response of patients whose immune systems may be ...rder, chemotherapy drugs, or because they are taki...f a transplant. The company launched the two new a...
(Date:12/1/2008)...Dec. 2 A study has foun...technique for imaging the breast, is not affected ...tus, two factors that limit the effectiveness of s...esults will be presented today at the annual meeti...SNA). , , "The ability of PEM to detect ca...
Breaking Medicine Technology:Gene Therapy Corrects Sickle Cell Disease in Laboratory Study 2Gene Therapy Corrects Sickle Cell Disease in Laboratory Study 3Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings 2Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings 3Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings 4IBT Laboratories Expands its Menu of Tests for Immune Deficiency 2New Mammography Technology Effective in Detecting Breast Cancer 2New Mammography Technology Effective in Detecting Breast Cancer 3New Mammography Technology Effective in Detecting Breast Cancer 4Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic 354 1Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic 354 2FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125 1775 1FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125 1775 2FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125 1775 3Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia 1770 1Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia 1770 2Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia 1770 3Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia 1770 4bioMETRX Inc Acquires Patent for Biometric Padlock 520 1bioMETRX Inc Acquires Patent for Biometric Padlock 520 2
...S--(BUSINESS WIRE)--July 8, 2007 - Cougar Biotechn...tive Phase I and Phase,II data on the Company,s pr...cetate) were presented at the European Society for...ently taking place,in Lugano, Switzerland. The dat...ons on Sunday, July 8, as part of the session for,...
...GA, ON, July 09, 2007 /PRNewswire-FirstCall/ - YM,...fies, develops,and commercializes differentiated p...at a study presented by investigators from Kinki,U...at the 11th,meeting of The Japanese Association fo...5-6, 2007 demonstrated the increased,radiosensitiv...
Other Medicine Technology:Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ESMO Conference 2Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ESMO Conference 3Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ESMO Conference 4Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ESMO Conference 5Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ESMO Conference 6YM BioSciences Announces Preclinical Data Confirming Nimotuzumab,Binds to the EGF Receptor and Potentiates Radiotherapy 2YM BioSciences Announces Preclinical Data Confirming Nimotuzumab,Binds to the EGF Receptor and Potentiates Radiotherapy 3YM BioSciences Announces Preclinical Data Confirming Nimotuzumab,Binds to the EGF Receptor and Potentiates Radiotherapy 4